Literature DB >> 8921960

Interleukin-7 induces T cell proliferation in the absence of Erk/MAP kinase activity.

J B Crawley1, J Willcocks, B M Foxwell.   

Abstract

Interleukin (IL)-7 and IL-2 are important lymphoproliferative cytokines which both use the gamma c chain as part of their respective receptors. To learn more of their signaling mechanisms a comparison was made of the patterns of intracellular tyrosine phosphorylated proteins induced by these cytokines in the murine T cell line, CT6. Several similarities were revealed in the tyrosine phosphorylated proteins induced. However, a notable subset of proteins of mainly < 60 kDa were only phosphorylated by IL-2. Characterization of the two most prominent bands of this subset, pp54 and pp42, revealed these to contain Shc and p42MAP/Erk kinase, respectively. Further studies confirmed that IL-7 was unable to induce the phosphorylation of either the p44MAP/Erk or p42MAP/Erk or activation of the kinases. Shc is involved in activation of p21ras, a key event in the signaling cascade, via p72raf and MEK, leading to MAP/Erk kinase (MAPK) activation. These data indicate that this pathway is not utilized by IL-7 and may not, therefore, be essential for cytokine-driven T cell proliferation. This possibility was supported by studies with the MEK inhibitor PD098059, which had no selective effect on CT6 proliferation induced by IL-2 as compared with IL-7, although the drug completely inhibited MAP/Erk phosphorylation induced by IL-2.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8921960     DOI: 10.1002/eji.1830261125

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Stimulated plasmacytoid dendritic cells impair human T-cell development.

Authors:  Heike Schmidlin; Wendy Dontje; Fedde Groot; Suzanne J Ligthart; Arnaud D Colantonio; Monique E Oud; Esther J Schilder-Tol; Marcel Spaargaren; Hergen Spits; Christel H Uittenbogaart; Bianca Blom
Journal:  Blood       Date:  2006-08-17       Impact factor: 22.113

Review 2.  Interlinking interleukin-7.

Authors:  Christina Kittipatarin; Annette R Khaled
Journal:  Cytokine       Date:  2007-09-04       Impact factor: 3.861

3.  Trophic factor withdrawal: p38 mitogen-activated protein kinase activates NHE1, which induces intracellular alkalinization.

Authors:  A R Khaled; A N Moor; A Li; K Kim; D K Ferris; K Muegge; R J Fisher; L Fliegel; S K Durum
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

4.  Hypoxia enhances FGF2- and VEGF-stimulated human placental artery endothelial cell proliferation: roles of MEK1/2/ERK1/2 and PI3K/AKT1 pathways.

Authors:  K Wang; Y-z Jiang; D-b Chen; J Zheng
Journal:  Placenta       Date:  2009-11-05       Impact factor: 3.481

Review 5.  Therapeutic targeting of IL-7Rα signaling pathways in ALL treatment.

Authors:  Sarah D Cramer; Peter D Aplan; Scott K Durum
Journal:  Blood       Date:  2016-06-06       Impact factor: 22.113

6.  Critical role for Rsk2 in T-lymphocyte activation.

Authors:  Jian-Xin Lin; Rosanne Spolski; Warren J Leonard
Journal:  Blood       Date:  2007-10-15       Impact factor: 22.113

7.  Interleukin (IL)-7 Signaling in the Tumor Microenvironment.

Authors:  Iwona Bednarz-Misa; Mariusz A Bromke; Małgorzata Krzystek-Korpacka
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  JunD/AP-1-mediated gene expression promotes lymphocyte growth dependent on interleukin-7 signal transduction.

Authors:  Shannon M Ruppert; Mounir Chehtane; Ge Zhang; Haiyan Hu; Xiaoman Li; Annette R Khaled
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

9.  Evidence of STAT5-dependent and -independent routes to CD8 memory formation and a preferential role for IL-7 over IL-15 in STAT5 activation.

Authors:  Roslyn A Kemp; Claire F Pearson; Georgina H Cornish; Benedict P Seddon
Journal:  Immunol Cell Biol       Date:  2009-12-01       Impact factor: 5.126

10.  Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells.

Authors:  Joao T Barata; Ana Silva; Joana G Brandao; Lee M Nadler; Angelo A Cardoso; Vassiliki A Boussiotis
Journal:  J Exp Med       Date:  2004-09-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.